Pre-Pulseless Takayasu Arteritis is Associated with Distinct Clinical and Angiographic Features but Similar Outcomes - A Cohort Study

• Published in: Mediterranean journal of rheumatology Vol. 34; no. 4; p. 427
• Main Authors: Misra, Durga Prasanna, Rathore, Upendra, Jagtap, Swapnil, Mishra, Prabhaker, Thakare, Darpan R, Singh, Kritika, Qamar, Tooba, Singh, Deeksha, Dixit, Juhi, Behera, Manas Ranjan, Jain, Neeraj, Ora, Manish, Bhadauria, Dharmendra Singh, Gambhir, Sanjay, Agarwal, Vikas, Kumar, Sudeep
• Format: Journal Article
• Language: English
• Published: Greece 01-12-2023
• Subjects: systemic vasculitis; outcome assessment; Takayasu arteritis; pre-pulseless; aortic arch syndromes
• ISSN: 2529-198X; 2529-198X
• DOI: 10.31138/mjr.301223.ppt

To compare the presentation, angiographic features, evolution, and prognosis of prepulseless Takayasu arteritis (TAK) with TAK with pulse loss.
Pre-pulseless TAK (defined as without pulse loss in the upper limbs, lower limb, carotid, or subclavian arteries) were identified from a cohort of TAK. Demographic characteristics, clinical features, angiographic involvement, baseline and longitudinal patterns of disease activity, medication use, and mortality rates were compared between pre-pulseless TAK and TAK with pulse loss. Adjusted odds ratios (aOR, with 95%CI) for categorical variables between pre-pulseless TAK and TAK with pulse loss were computed using multivariable-adjusted logistic regression models. Time-to-event data was compared using hazard ratios (HR) with 95%CI.
Compared with TAK with pulse loss, pre-pulseless TAK (91/238, 38.24%) more frequently had deranged renal function (aOR 4.43, 95%CI 1.58-12.37) and Hata's type IV disease (aOR 8.02, 95%CI 2.61-24.65), and less often had pulse or blood pressure asymmetry (aOR 0.34, 95%CI 0.18-0.63), limb claudication (aOR for upper limb 0.38, 95%CI 0.18-0.82, for lower limb 0.28, 95%CI 0.12-0.68), right subclavian (aOR 0.45, 95%CI 0.23-0.90) or left carotid artery involvement (aOR 0.42, 95%CI 0.21-0.84). Only two patients with pre-pulseless TAK developed pulse loss on follow-up. Despite fewer pre-pulseless TAK having active disease at presentation, similar proportions of patients in both groups had active disease on follow-up. Survival was similar in both groups (HR for mortality 0.41, 95%CI 0.09-1.90).
Pulse loss on follow-up is uncommon in those with prepulseless TAK. Pre-pulseless TAK is associated with similar long-term outcomes to TAK with pulse loss.